scispace - formally typeset
C

Charles A. Dinarello

Researcher at University of Colorado Denver

Publications -  1073
Citations -  152254

Charles A. Dinarello is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Interleukin & Cytokine. The author has an hindex of 190, co-authored 1058 publications receiving 139668 citations. Previous affiliations of Charles A. Dinarello include University of Guadalajara & Pennsylvania State University.

Papers
More filters
Journal ArticleDOI

Modulation of Acute Myeloblastic Leukemia (AML) Cell Proliferation and Blast Colony Formation by Antisense Oligomer for IL-1 Beta Converting Enzyme (ICE) and IL-1 Receptor Antagonist (IL-1ra)

TL;DR: Results were obtained on CFU-AML colony formation, showing inhibition at higher IL-1ra doses, but in a few AML cases stimulatory effect at lower IL-2RA doses, suggesting a novel regulatory pathway for IL- 1 receptor engagement.
Journal ArticleDOI

Transcription, translation and secretion of interleukin 1 and tumor necrosis factor: effects of tebufelone, a dual cyclooxygenase/5-lipoxygenase inhibitor.

TL;DR: It is demonstrated that tebufelone enhances IL 1(α and β) and TNF‐α synthesis at concentrations which suppress leukotriene formation, arguing against a role of 5‐LO products as necessary intermediates of IL 1 (α andβ) andTNF‐ α synthesis.
Journal ArticleDOI

Histone deacetylase inhibitor suppresses virus-induced proinflammatory responses and type 1 diabetes

TL;DR: The data suggest that targeting innate immune pathways with inhibitors of HDAC might represent an efficient therapeutic strategy for preventing T1D, and ITF-2357 therapy may be an efficient approach to prevent T1d in genetically susceptible individuals.